Healthpeak Properties (DOC) FY2025 results: revenue $2.8 billion, up 4.5% on the year
Healthpeak Properties, Inc. (DOC) reported revenue of $2.8 billion for fiscal 2025, the year ended 31 December 2025, up 4.5% on the year before. Net income was $71 million, down 70.7%, and diluted earnings per share $0.10. The figures are the company's own, from the 10-K it filed with the SEC on 3 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 4 new, 1 kept.
- Same-store cash NOI grew 3.9%: Total merger-combined same-store cash (adjusted) NOI grew 3.9% in Q4 and 4.0% for full-year 2025, with Outpatient Medical, Lab and Life Plan as the three reported segments.
- Outpatient Medical and Lab same-store growth: Outpatient Medical same-store cash NOI grew 4.1% in Q4 and 3.9% for 2025. Lab was down 0.3% in Q4 and up 1.5% for 2025. Outpatient Medical was 54.1% and Lab 33.9% of Q4 same-store NOI.
- Life Plan same-store growth accelerated: Life Plan same-store cash NOI grew 16.7% year over year and 15.4% sequentially in Q4, and 12.6% for full-year 2025.
- Gateway Crossing campus bought for $600 million: Healthpeak acquired Gateway Crossing, a 1.4 million square foot campus in South San Francisco, for $600 million at a low-6% going-in yield. The campus is 63% occupied.
- Janus Living IPO planned: Management said the IPO is intended to unlock value immediately, given the public markets' difficulty valuing the senior housing portfolio at its current scale within Healthpeak.
From this 10-K
Healthpeak owns, operates and develops real estate for healthcare discovery and delivery in the United States: outpatient medical buildings, hospitals, laboratory buildings and senior housing. It was founded in 1985, is a Maryland corporation and a self-administered REIT, and is structured as an umbrella partnership REIT with substantially all assets and operations held through Healthpeak OP. Head office is in Denver.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 2,823 | 2,700 | 2,181 | +4.5% | |
| Cost of revenue | n/a | 1,075 | 902 | ||
| Gross profit | n/a | 1,626 | 1,279 | ||
| Gross margin | n/a | 60.2% | 58.6% | ||
| Operating income | 214 | 35.1 | 222 | +510.1% | |
| Operating margin | 7.6% | 1.3% | 10.2% | ||
| Interest expense | 305 | 280 | 200 | +8.8% | |
| Pre-tax income | 284 | 273 | 315 | +4.1% | |
| Income tax | 9.3 | 4.3 | -9.6 | +113.4% | |
| Effective tax rate | 3.3% | 1.6% | -3.1% | ||
| Net income | 71.3 | 243 | 306 | -70.7% | |
| Net margin | 2.5% | 9.0% | 14.0% | ||
| Diluted EPS | $0.10 | $0.36 | $0.56 | -72.2% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 1,252 | 1,070 | 956 | +17.0% | |
| Capital expenditure | 895 | 737 | 775 | +21.5% | |
| Free cash flow | 357 | 334 | 182 | +7.0% | |
| Free cash flow margin | 12.6% | 12.4% | 8.3% | ||
| Cash from investing | -1,035 | -114 | -577 | ||
| Cash from financing | 136 | -941 | -337 | ||
| Depreciation and amortisation | 1,059 | 1,057 | 750 | +0.2% | |
| Share-based compensation | 14.4 | 15.5 | 14.5 | -7.3% | |
| Buybacks | 97.1 | 191 | 6.5 | -49.1% | |
| Dividends paid | 849 | 795 | 657 | +6.8% | |
| Dividend per share | $1.22 | $1.20 | $1.20 | +1.7% | |
| Diluted shares, weighted | 696m | 676m | 547m | +2.9% | |
| Shares outstanding at period end | 695m | 699m | 547m | -0.6% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 7,500 | 8,401 | 6,350 | -10.7% | |
| Non-controlling interest | 643 | 654 | 526 | -1.7% | |
| Redeemable equity | 160 | 2.6 | 48.8 | +6,014.2% | |
| Debt | 9,848 | 8,716 | 6,876 | +13.0% | |
| Other liabilities | 2,186 | 2,165 | 1,898 | +1.0% | |
| Total liabilities and equity | 20,336 | 19,938 | 15,699 | +2.0% | |
| Goodwill | 68.5 | 68.5 | 18.0 | 0.0% | |
| Intangible assets | 655 | 817 | 314 | -19.9% | |
| Loans | 606 | 656 | 218 | -7.6% | |
| Cash and equivalents | 467 | 120 | 118 | +290.1% | |
| Other assets | 18,539 | 18,277 | 15,031 | +1.4% | |
| Total assets | 20,336 | 19,938 | 15,699 | +2.0% |
10-K for the year ended 31 December 2025, filed 3 February 2026: the filing.